Doctors perform surgery (generic) R 370.
(photo credit: REUTERS/Swoan Parker)
The Health Ministry’s pharmaceutical division has asked doctors to be vigilant
for cases of pancreatic infections and pancreatic cancer in diabetics taking
incretins, drugs commercialized as Januet, Januvia, Byetta, Victoza, Galvus,
Eucreas and Onglyza, among others.
Incretins are gastrointestinal
hormones that increase the amount of insulin released from the beta cells of the
islets of Langerhans in the pancreas.
The announcement on Monday followed
a warning by the US Food and Drug Administration and its European counterpart,
EMA, which are following up a “possible connection” between taking the drugs and
developing pancreatic infections or cancer in the organ.
The ministry and
the National Diabetes Council have been asked to raise physicians’ awareness of
possible side effects from this drug family. The ministry said the number of
reports of side effects here seem to be lower than expected.
noted such side effects were asked to report them via an electronic report to
the ministry at http://forms.gov.il/globaldata/getsequence/getsequence.aspx?formType=Adv ersEffectMedic@moh.health.gov.il